Cancer BiologybioRxivPreprint
Characterization of a novel humanized heavy chain antibody targeting endogenous retroviruses with anti-lymphoma activity
Filippo Spriano, Luciano Cascione, Jacopo Sgrignani…·Francesco Bertoni
This study identifies HERV-K as a therapeutic target in DLBCL, develops a humanized nanobody with anti-lymphoma activity, and shows its potential through antibody-dependent cytotoxicity.
2 citations